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Pancreatic adenocarcinoma is among the most fatal of
gastrointestinal cancers. Recent in vitro studies showed
that tumors are able to develop several escape mecha-
nisms. We hypothesized that regulatory T cells (Treg) may
impair anti-tumor immune responses. Therefore, we
investigated the role of immune-mediated pathways in
invasive pancreatic cancer.
Blood and tumor samples were analyzed in 14 patients
undergoing surgery for pancreatic adenocarcinoma
(UICC stages II to IV) by ELISA, immunohistology, and
real-time RT-PCR techniques. The expression, distribu-
tion, and protein products of the following gene classes
were analyzed:Treg (CD4, CD25, CD8, IDO, Foxp3), co-
stimulatory molecules (CD28, CTLA-4), transcription fac-
tors (GITR, GATA-3), apoptotic markers (Bcl-2, Fas, FasL),
cytokines (IFN-γ, IL-6/10), tumor suppressors (p53, APC),
and tumor marker (CEA).
Immunohistogical/-fluorescence doublestaining corre-
sponded with the PCR results for the various markers
(CD4+CD25+, CD8+CD28+, Bcl-2, Fas/FasL, p53/CD4+,
CEA/CD4+, APC). Using hierarchical clustering methods
the comparison of all tumor tissues revealed two samples
with a highly different gene expression pattern. The dis-
similarity was associated with the UICC stage of the
patients. Compared to UICC III or IV, stage II showed a
significantly lower expression of most genes (14 out of
19). The other characteristic difference in the gene expres-
sion pattern of the individual sample was due to the local-
ization of the analyzed tissue within the tumor. Samples
from the tumor center showed a markedly lower expres-
sion of the immune-response related genes than samples
from the tumor border line. Gene expression related to
immune activation and regulation was low (CD69<Foxp3
& CTLA-4<CD28 & IFN-γ & IL-10 & CD4<IDO & CD25 &
GATA-3<Fas & IL-6) in all samples obtained from the
tumor center. The anti-apoptotic genes Bcl-2 and GITR
showed a higher expression than the pro-apoptotic genes
Fas and FasL. The highest expression was measured for
APC>CEA>Bcl-2>CD8. IFN-γ & CTLA4 & CD28; CD4 &
IL-10 & Foxp3 & CD25; and Bcl-2 & APC were clustered
together analyzing the patterns of gene expression among
the different samples.
Invasive pancreatic carcinomas show relatively low levels
in expression of genes associated with immune activation
and regulation. This might indicate insufficient anti-
tumor immune responses against the tumor. In addition,
gene expression profiles differ significantly between sam-
ples obtained from the tumor center versus the tumor bor-
der line.
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